Edwin Moses, the former chief executive of Ablynx NV, has been appointed chairman of the board of directors of LabGenius Ltd, a protein engineering company that uses artificial intelligence, robotic automation and synthetic biology to discover new therapeutics. Dr Moses was CEO of Ablynx for more than 12 years until that company’s agreed takeover by Sanofi SA in 2018. He has more than 25 years of experience in the life science and biotechnology sectors including board level positions, primarily as chairman, in more than 15 companies.
LabGenius announced the appointment on 20 April 2020.
Copyright 2020 Evernow Publishing Ltd.